Investors head into a busy stretch of the earnings season in the week of 8–12 June, with a select but influential group of companies from both London and New York markets set to report. While the calendar is lighter than peak reporting periods, results from a mix of technology, consumer, and industrial names will offer important insight into global demand trends, margins, and the outlook for the second half of the year.
In the US, Oracle (NYSE:ORCL) will be the standout release, drawing close attention to cloud infrastructure growth, AI-related demand, and enterprise spending resilience. Alongside Oracle, updates from companies such as GameStop (NYSE:GME) and Adobe (NASDAQ:ADBE) will provide additional signals on consumer behaviour and digital economy momentum, and whether the AI software sell-off of a few of months back has been nipped in the bud.
AI ‘scare trade’ continues to rattle investors
In London, attention will centre on Halma (LON:HLMA), whose consistent growth profile and exposure to safety, environmental, and healthcare markets make it a key bellwether for defensive industrial demand. Fevertree Drinks (LON:FEVR) will also be closely watched for commentary on consumer spending, pricing power, and recovery in hospitality channels. Additional UK names expected to report include Pennon (LON:PNN), Oxford Instruments (LON:OXIG) and Wizz Air (LON:WIZZ), covering domestic water supply, science and tech tools, and European flights—each offering a different lens on the UK economic backdrop.
Across both markets, investors will be looking for three main themes:
- Demand resilience in the face of still-elevated interest rates
- Margin trends, particularly as cost pressures ease unevenly
- Forward guidance, with companies updating expectations for the remainder of 2026
While the volume of results may be modest, the diversity of sectors and geographies represented means this week’s earnings could still play an outsized role in shaping short-term market sentiment.
Halma (LON:HLMA)
Global analytics, technology and safety group Halma (LON:HLMA) posts its FY results on Thursday 11 June. Following a strong H1, which showed organic revenue growth of 16.7%, the firm said in March it made ‘further strong progress’ in H2.
Its latest FY guidance is for continued mid-teens organic revenue growth and an EBIT margin of around 22% against 21.7% previously. Those figures are consistent with the consensus, which sees sales up 14% and an EBIT margin of 22.2%.
Where the company may surprise is with non-organic growth, after a record investment in acquisitions last year. Since the H1 results, the firm has made three purchases, two in the safety sector and one in healthcare.
Given Halma’s success in integrating acquisitions and enhancing returns, we wouldn’t be surprised if the results beat forecasts. We might also see the firm raise its revenue and earnings guidance for the year to March 2027.
Halma forecasts
| FY 2026 | FY 2027 | |
| Revenue (£m) | 2,557 | 2,826 |
| Pre-tax profit (£m) | 543 | 609 |
| Earnings per share (p) | 110.7 | 123.9 |
Source: company-compiled consensus
Oracle (NYSE:ORCL)
If Oracle’s (NYSE:ORCL) stock significantly moves when the tech infrastructure giant reports Q4 and FY 2026 earnings on Wednesday, 10 June, it’s unlikely to be headline numbers that do the heavy lifting. Markets are far more likely to zoom in on whether its cloud and AI growth story continues to justify the company’s premium valuation.
The most important metric will be Oracle Cloud Infrastructure (OCI) growth. Oracle has positioned itself as a major beneficiary of the AI infrastructure boom, with demand from customers such as OpenAI and other large AI developers driving rapid expansion. In recent quarters, OCI growth has significantly outpaced the wider business, while cloud revenue has become Oracle’s main growth engine.
Investors should also watch Remaining Performance Obligations (RPO), Oracle’s contracted revenue backlog. This figure has surged as companies commit to long-term cloud and AI infrastructure agreements, providing visibility into future revenue growth. Any slowdown in backlog growth could raise questions about demand sustainability.
Oracle Q4 forecasts
| Q4 2025 | Q4 2026 | YoY Growth | Q1 2027 | |
| Revenue ($bn) | 15.9 | 19.1 | ~20% | 19.0 |
| EPS ($) | 1.70 | 1.96 | ~15% | 1.68 |
Source: Koyfin
Capital expenditure is another key area. Oracle executed a historic $45 billion to $50 billion cash call in February 2026, tapping both bond and equity markets to fund the explosive expansion of OCI, data centres, GPUs and cloud capacity to meet AI demand. While these investments support future growth, they can pressure free cash flow and margins in the near term. Finding the right balance of expansion and profitability remains a tricky challenge.
Finally, guidance for FY2027 may prove more influential than the FY2026 results themselves. Any updates on AI-related contracts, cloud capacity expansion or revenue targets could have a significant impact on market expectations and Oracle’s share price.
Oracle to jump 11% as growth and guidance spark rally
Fevertree Drinks (LON:FEVR)
Shares in Fevertree Drinks (LON:FEVR) have drifted lower in recent months as investors weigh the impact of geopolitical uncertainty and a weak spirits market on the mixer supplier’s recovery prospects. Increased competition and the cost-of-living pressures facing consumers are also depressing the posh tonic-to-ginger beer brand’s stock price.
So investors will be hoping for news of improved UK trading in FY26-to-date when Fevertree updates the market on 9 June. Signs of an uptick in gin demand, and progress with Fevertree’s diversification beyond tonic, would be well-received.
But the most significant upside catalyst would positive news related to the AIM-listed firm’s transformational partnership with Molson Coors (NYSE:TAP) in the US, Fevertree’s biggest growth market.
FY26 consensus calls for a rise in sales from £375.3 million to £402.1 million and a pre-tax profits jump from £29.9 million to £40.4 million. Sharesify wouldn’t be surprised to see cash generative Fevertree react to recent share price weakness by extending its share buyback.
Fevertree forecasts
| FY 2026 | FY 2027 | |
| Total sales (£m) | 402.1 | 435.1 |
| Pre-tax profit (£m) | 40.4 | 54.7 |
| Earnings per share (p) | 29.5 | 39 |
Source: company-compiled consensus
You might also like:
